These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7682515)

  • 21. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
    Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
    J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between first- and second-generation test for anti-hepatitis C virus antibodies in hemodialysis patients.
    Da Porto A; Poli P; Calzavara P; Castelletto MR; Adami A; Cascone C; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):367-8. PubMed ID: 1323794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibodies to hepatitis C virus in patients undergoing hemodialysis in Salvador, BA, Brazil].
    Santana GO; Cotrim HP; Mota E; Paraná R; Santana NP; Lyra L
    Arq Gastroenterol; 2001; 38(1):24-31. PubMed ID: 11582961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
    Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
    Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma.
    Sakamoto N; Enomoto N; Marumo F; Sato C
    J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence of anti-HCV antibody positivity and seroconversion incidence in hemodialysis patients].
    Biamino E; Caligaris F; Ferrero S; Montalcini G; Bongiorno P; Scuvera I
    Minerva Urol Nefrol; 1999 Jun; 51(2):53-5. PubMed ID: 10429410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
    Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
    Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women.
    Marranconi F; Fabris P; Stecca C; Zampieri L; Bettini MC; Di Fabrizio N; de Lalla F
    Infection; 1994; 22(5):333-7. PubMed ID: 7531180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
    Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
    Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-HCV seroprevalence in pregnant women in France.
    Roudot-Thoraval F; Pawlotsky JM; Deforges L; Girollet PP; Dhumeaux D
    Gut; 1993; 34(2 Suppl):S55-6. PubMed ID: 7686117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis.
    Ng YY; Lee SD; Wu SC; Yang WC; Chiang SS; Huang TP
    J Med Virol; 1991 Dec; 35(4):263-6. PubMed ID: 1724984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the positivity of the test for anti-HCV considerations in dialized patients.
    Avella F; Irlando A; Scancariello G; Iovino R
    Nephron; 1992; 61(3):341. PubMed ID: 1323785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis C virus markers in Sri Lankan patients with alcoholic cirrhosis.
    De Silva HJ; Vitarana T; Ratnatunga N; Breschkin A; Withane N; Kularatne WN
    J Gastroenterol Hepatol; 1994; 9(4):381-4. PubMed ID: 7524722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzymed-linked immunosorbent assay.
    Schlipköter U; Gladziwa U; Cholmakov K; Weise A; Rasshofer R; Lorbeer B; Luz N; Deinhardt F; Roggendorf M
    Med Microbiol Immunol; 1992; 181(3):173-80. PubMed ID: 1381808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.